Article
The approval of the newest botulinum toxin product available in the United States underscores the value of the Food and Drug Administration drug approval process and the importance of using branded products, says Mich?l H. Gold, M.D.
POLL: Are You Attending the 44th Annual Fall Clinical Dermatology Conference?
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Navigating Complexities and Unmet Needs of Chronic Hand Eczema
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Facing Challenges in Pediatric Plaque Psoriasis
Insights into the Association Between Pruritus and Liver Disease